Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

COYA Coya Therapeutics Inc

7,685

-0,225 (-2,84%)

Zuletzt aktualisiert: 21:43:07

Verzögert um 15 Minuten

Form D - Notice of Exempt Offering of Securities

Coya Therapeutics (NASDAQ:COYA)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Coya Therapeutics Charts.

Coya Therapeutics (NASDAQ:COYA)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Coya Therapeutics Charts.

News Coya Therapeutics Inc

Coya Therapeutics Announces Inclusion in the MSCI USA Micro Cap Index
Dienstag 28 Mai 2024 (8 Stunden vor) • Business Wire

Coya Therapeutics Announces the Completion of a Controlled Phase 2 Study of Low Dose Interleukin-2 (LD IL-2) in Patients with Alzheimer’s Disease
Mittwoch 22 Mai 2024 (6 Tage vor) • Business Wire

Form 8-K - Current report
Montag 20 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Coya Therapeutics Announces $5 Million Strategic Investment by the Alzheimer’s Drug Discovery Foundation (ADDF)
Montag 20 Mai 2024 (1 Woche vor) • Business Wire

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 9 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 9 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Coya Therapeutics Provides a Corporate Update and Reports Unaudited First Quarter 2024 Financial Results
Donnerstag 9 Mai 2024 (3 Wochen vor) • Business Wire

Form 8-K - Current report
Mittwoch 8 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Coya Therapeutics Presents Updated ALS Biomarker Data at the 2nd Annual Johnson Center Symposium
Freitag 26 April 2024 (1 Monat vor) • Business Wire

Coya Therapeutics to Participate in the Mizuho Neuroscience Summit
Montag 22 April 2024 (1 Monat vor) • Business Wire

Coya Therapeutics to Participate in the 3rd Annual ALS Drug Development Summit
Donnerstag 18 April 2024 (1 Monat vor) • Business Wire

Coya Therapeutics Scientific Advisory Board Chairman Dr. Stanley Appel to Present Updated ALS Biomarker Data at the 2nd Annual Johnson Center Symposium
Montag 8 April 2024 (2 Monate vor) • Business Wire

Weitere Coya Therapeutics Inc News-Artikel

BNP Paribas Issuance

JPMorgan Funds ETFs Irel...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen